Ascendis Pharma A/SASNDNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-16.47%
↑ 99% vs avg
Percentile
P85
Within normal range
Streak
5 yr
Consecutive growthExpanding
Average
-2357.76%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -16.47% | +79.4% |
| 2024 | -79.76% | +48.3% |
| 2023 | -154.16% | +85.1% |
| 2022 | -1034.07% | +77.9% |
| 2021 | -4688.12% | +20.1% |
| 2020 | -5865.21% | -272.9% |
| 2019 | -1572.79% | -10.8% |
| 2018 | -1419.32% | +80.2% |
| 2017 | -7181.96% | -358.7% |
| 2016 | -1565.78% | - |